Higher success with ocriplasmin for vitreomacular traction found in certain population groups

SEATTLE — When considering using ocriplasmin for vitreomacular traction, the most important consideration is the size of the macular traction, but age, presence of epiretinal membrane and whether the eye is phakic also need to be taken into account, according to a speaker here. Speaking at the Cole Eye Institute Retina Summit held before the Association for Research in Vision and Ophthalmology meeting, Peter K. Kaiser, MD, said that if the macular adhesion is broad, patients did not do as well as patients with focal areas of adhesion.

Full Story →